Navigation Links
Nanobiosym awarded $2 million DTRA contract
Date:9/26/2007

MEDFORD, Mass., September 26, 2007 Nanobiosym Inc., announced today that it has been awarded a highly competitive $2 million contract from the United States Defense Threat Reduction Agency (DTRA), a branch of the US Department of Defense. The winners of this award were selected after an intense competition among many of the nations leading US academic, government, and industrial labs.

Nanobiosym, and its commercial partner Nanobiosym Diagnostics, have been privately developing Gene-RADAR, a portable nanotechnology-enabled platform, that can rapidly and accurately detect genetic fingerprints from any biological organism. The companys vision is to give patients worldwide real-time access to their own diagnostic information via low-cost handheld devices. Nanobiosym Diagnostics also seeks to leverage its nanotechnology platform to enable portable real-time detection of food and air-borne pathogens, as well as water testing, animal and crop testing, and screening of blood and transplant organs.

We are delighted that DTRA has recognized our unique proprietary technological platform with this award, said Dr. Anita Goel, M.D., PhD., Chairman and CEO of Nanobiosym. This is our first defense contract and is a major step towards establishing the US government as one of our long-term customers. Nanobiosym has been previously recognized by several other prominent awards, including multiple rounds of funding from the Defense Advance Research Project Agency (DARPA), the Air Force Office of Scientific Research (AFOSR), and the U.S. Department of Energy (DOE). Nanobiosym shares DTRAs strategic mission to reduce the threat of biological warfare and bioterrorism and during the course of the DTRA contract plans to validate the use of Nanobiosyms proprietary technology platform for emerging biodefense applications. In the coming years, we envision a significant paradigm shift in healthcare where the ability to diagnose disease is taken out of a pathology lab and brought into doctors clinics, peoples homes, and even rural villages. said Dr. Goel. This is similar to the paradigm shift that occurred in the telecom industry when communications and computing devices became portable. Nanobiosym is also actively adapting its Gene-RADAR system to address unmet healthcare needs in the developing world, where the lack of basic infrastructure often precludes effective diagnostics.


'/>"/>

Contact: NBS Media & Public Relations
Info@nanobiosym.com
781-391-7979
Feinstein Kean Healthcare
Source:Eurekalert

Related biology news :

1. TGen awarded $7.1 million to accelerate brain disease research
2. A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020
3. UCLA launches $20 million stem cell institute to investigate HIV, cancer and neurological disorders
4. Six million Africans face famine because of locusts, drought
5. Retrovirus struck ancestors of chimpanzees and gorillas millions of years ago, but did not affect ancestral humans
6. Evidence of 600-million-year old fungi-algae symbiosis discovered in marine fossils
7. $5.1 billion would save 6 million children
8. Health costs soar as 60 million Americans classed as obese
9. Malaria killing a million a year
10. $6.5 Million Grant for Microarray Center at Yale School of Medicine
11. MSU researchers receive $4 million grant to uncover gene functions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/21/2016)... 2016 NuData Security announced today that Randy ... principal product architect and that Jon Cunningham ... development. Both will report directly to Christopher ... reflect NuData,s strategic growth in its product and ... demand and customer focus values. ...
(Date:6/16/2016)... , June 16, 2016 ... is expected to reach USD 1.83 billion by ... View Research, Inc. Technological proliferation and increasing demand ... are expected to drive the market growth. ... The development of advanced multimodal techniques ...
(Date:6/9/2016)... innovation leader in attendance control systems is proud to announce the introduction of fingerprint ... sure the right employees are actually signing in, and to even control the opening ... ... ... Photo ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... ... December 01, 2016 , ... ... for North American hospitals, will present its chain-of-custody solution for tracking and securing ... Las Vegas, Nev., Dec. 4-8, 2016. , Aerocom has a proven solution for ...
(Date:12/2/2016)... IL (PRWEB) , ... December 01, 2016 , ... ... to congratulate long-term client Nanowear on their recent FDA Class II 510(k) clearance ... cleared a significant hurdle in commercializing remote cardiac monitoring devices that rely on ...
(Date:12/2/2016)... The immunohistochemistry (IHC) market is projected to reach ... during the forecast period of 2016 to 2021 dominated by immunohistochemistry ... the largest share of immunohistochemistry (IHC) market, by end user.   ... , , ... across 225 pages, profiling 10 companies and supported with 181 tables ...
(Date:11/30/2016)... ALBANY, New York , November 30, 2016 /PRNewswire/ ... exceptionally consolidated as a few players hold a dominant ... Lonza Group, Charles River Laboratories International, Inc., and Merck ... global market in 2015. Transparency Market Research observes that ... they are focused on development products that are do ...
Breaking Biology Technology: